A new research study conducted by the UK Health Security Agency (UKHSA) has revealed a potential benefit of the nasal spray flu vaccine for children. The UKHSA looked at data from 2013-17 and found that areas where the flu vaccine was given saw lower rates of Group A Strep infections compared to areas where the vaccine was not widely available.
The flu vaccine is currently free for children aged two to four years old, all primary school children, some secondary school-aged children, and children aged two to 17 years with long-term health conditions. The UKHSA is also advising everyone eligible for the flu vaccine to get it, as hospital admission rates for flu-related illnesses have risen sharply in the past week.
At the same time, the UKHSA is warning of the dangers posed by both flu and COVID-19, with infection levels now similar to where they were at the end of September. The nasal spray vaccine is the best protection against severe illness, and the UKHSA is urging everyone who is eligible to get their booster jab.
In conclusion, the UKHSA research has suggested that the nasal spray flu vaccine could be beneficial in helping to prevent Group A Strep infections in children. The UKHSA is advising everyone eligible for the flu vaccine to get it, as it is the best protection against severe illness. Finally, the UKHSA is warning of the dangers posed by both flu and Covid-19.